<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/837BAF8D-D113-4776-8C2C-1AD63DD26B27"><gtr:id>837BAF8D-D113-4776-8C2C-1AD63DD26B27</gtr:id><gtr:name>Catsci Ltd</gtr:name><gtr:address><gtr:line1>CBTC2 CAPITAL BUSINESS PARK , WENTLOOG</gtr:line1><gtr:city>CARDIFF</gtr:city><gtr:postCode>CF3 2PX</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/837BAF8D-D113-4776-8C2C-1AD63DD26B27" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>837BAF8D-D113-4776-8C2C-1AD63DD26B27</gtr:id><gtr:name>Catsci Ltd</gtr:name><gtr:address><gtr:line1>CBTC2 CAPITAL BUSINESS PARK , WENTLOOG</gtr:line1><gtr:city>CARDIFF</gtr:city><gtr:postCode>CF3 2PX</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>93686.0</gtr:offerGrant><gtr:projectCost>124914.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F147BD27-7F0C-4ECA-96D1-57C429B623C8" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>F147BD27-7F0C-4ECA-96D1-57C429B623C8</gtr:id><gtr:name>Prozomix Limited</gtr:name><gtr:address><gtr:line1>Unit 3 
Station Court
Haltwhistle</gtr:line1><gtr:city>Northumberland</gtr:city><gtr:postCode>NE49 9HN</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>56702.0</gtr:offerGrant><gtr:projectCost>75602.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A20E93AB-C252-4174-B1F6-54856058C583"><gtr:id>A20E93AB-C252-4174-B1F6-54856058C583</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Moseley</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131918"><gtr:id>735F9DA6-4668-4460-A8CD-B51D14B35ACD</gtr:id><gtr:title>Ketoreductase Catalysed Manufacture of Active Pharmaceutical Ingredients</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131918</gtr:grantReference><gtr:abstractText>A consortium comprising of Prozomix, CatScI Ltd and Charnwood Technical Consulting has been established as part of the Innovate UK?s IB Catalyst. The key goal of the project is to develop a technology platform for an IB route to active pharmaceutical ingredients to replace current processes manufactured through traditional chemical manufacturing techniques. The new technology has the potential to significantly reduce manufacturing costs whilst concomitantly allowing an increased output of the active pharmaceutical ingredient with a more robust supply chain. Additionally, this will have the added benefits of generating a more sustainable process as it will be more energy efficient and less reliant on hydrocarbon and precious metal based technologies.</gtr:abstractText><gtr:fund><gtr:end>2016-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>150388</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131918</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>